GeneID: 421



Names

Common Name: FGF23 Type: Gene
Chromosome: 12 (NC_000012.12) Locus: NG_007087.1 (FGF23)
HUGO Symbol: FGF23 Full Name: fibroblast growth factor 23
Exons: 3 Introns: 2

Description:
FGF23 encodes a member of the fibroblast growth factor family of proteins, which possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. FGF23 acts as a negative regulator of bone metabolism and parathyroid hormone production. It is secreted as active intact protein (iFGF23) in bone and BM erythroid cells, and is inactivated by cleavage in c-terminal fragment (cFGF23). High levels of FGF23 were reported in beta-thalassemia patients with hypoparathyroidism. Erythropoietin (EPO) is an inducer of FGF23. Increased levels of EPO in β-thalassemia induce FGF23 overproduction in bone and BM erythroid cells via ERK1/2 and STAT5 pathways, negatively affecting bone and BM niche homeostasis. FGF23 serves as a candidate molecular link connecting anemia, bone, and the HSC niche in β-thalassemia.

Synonyms: ADHR , FGFN , HYPF , HFTC2 , HPDR2 , PHPTC

Comments:
N/A

Number of entries/variants: 0

IthaScore

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. Saki F, Salehifar A, Kassaee SR, Omrani GR, Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study., BMC Nephrol, 21(1), 482, 2020 PubMed
  2. Aprile A, Raggi L, Bolamperti S, Villa I, Storto M, Morello G, Marktel S, Tripodo C, Cappellini MD, Motta I, Rubinacci A, Ferrari G, Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia., Sci Transl Med, 15(698), eabq3679, 2023 PubMed
Created on 2021-01-25 16:06:27, Last reviewed on 2024-01-22 15:22:08 (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.